CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
48 hedge funds and large institutions have $64.9M invested in Crescent Biopharma, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 22 reducing their positions, and 14 closing their positions.
Holders
48
Holders Change
-10
Holders Change %
-17.24%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
22
Closed
14
Calls
$1.08M
Puts
$763K
Net Calls
+$320K
Net Calls Change
+$188K
Top Buyers
Top Sellers
1 |
1
Dimensional Fund Advisors
Austin,
Texas
|
$1.98M |
2 |
2
Millennium Management
New York
|
$981K |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$67K |
4 |
E
4
Ergoteles
New York
|
$0 |
5 |
5
Renaissance Technologies
New York
|
$1.31M |